Jacques Rouëssé
- Oncology top 1%
- Cancer Treatment and Pharmacology 24
- Vascular Tumors and Angiosarcomas 8
- Neutropenia and Cancer Infections 7
- Cancer Research top 1%
- Breast Cancer Treatment Studies 26
-
- Sarcoma Diagnosis and Treatment 17
- Lung Cancer Treatments and Mutations 10
-
- Breast Lesions and Carcinomas 13
- Rheumatology top 1%
-
- Neuroblastoma Research and Treatments 8
- Co-authors
- G ContessoM TrojaniMarc DavidF. BonichonJean‐Michel CoindreA. de MascarelJ.‐F. GoussotC Lagarde
- Journals
- Cancer (9 papers)Journal of Clinical Oncology (9 papers)European Journal of Cancer (7 papers)
- Partner nations
- FranceItalyUnited Kingdom
In The Last Decade
Jacques Rouëssé
111 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 2.3k
- Cancer Research 1.1k
- Pulmonary and Respiratory Medicine 2.2k
- Pathology and Forensic Medicine 893
- Rheumatology 618
Countries citing papers authored by Jacques Rouëssé
This map shows the geographic impact of Jacques Rouëssé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Rouëssé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Rouëssé more than expected).
Fields of papers citing papers by Jacques Rouëssé
This network shows the impact of papers produced by Jacques Rouëssé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Rouëssé. The network helps show where Jacques Rouëssé may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jacques Rouëssé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 0 | |
| 2 | 2019 | 22 | |
| 3 | 2014 | 3 | |
| 4 | 2014 | 4 | |
| 5 | 2011 | 2 | |
| 6 | 2008 | 17 | |
| 7 | 2007 | 1 | |
| 8 | 2006 | 142 | |
| 9 | 2004 | 0 | |
| 10 | Association mitomycine-vinorelbine en deuxième ligne chimiothérapique dans le cancer du sein métastatique | 1998 | 3 |
| 11 | 1993 | 7 | |
| 12 | 1992 | 240 | |
| 13 | 1990 | 34 | |
| 14 | 1990 | 7 | |
| 15 | 1990 | 24 | |
| 16 | 1989 | 48 | |
| 17 | Chimiothérapie première dans les sarcomes des parties molles considérés comme inopérables. | 1983 | 3 |
| 18 | [Conservative treatment of breast cancer]. | 1978 | 2 |
| 19 | [Anatomo-pathological factors in breast cancer prognosis]. | 1973 | 2 |
| 20 | Facteurs anatomo-pathologiques du pronostic des cancers du sein | 1973 | 5 |
About Jacques Rouëssé
Jacques Rouëssé is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 117 papers that have together received 4.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (26 papers), Cancer Treatment and Pharmacology (24 papers), Sarcoma Diagnosis and Treatment (17 papers), Breast Lesions and Carcinomas (13 papers), Lung Cancer Treatments and Mutations (10 papers), Neuroblastoma Research and Treatments (8 papers), Vascular Tumors and Angiosarcomas (8 papers) and Neutropenia and Cancer Infections (7 papers). The work is most often cited by research in Oncology (2.3k citations), Cancer Research (1.1k citations) and Pulmonary and Respiratory Medicine (2.2k citations). Jacques Rouëssé has collaborated with scholars based in France, Italy and United Kingdom. Frequent co-authors include G Contesso, M Trojani, Marc David, F. Bonichon, Jean‐Michel Coindre, A. de Mascarel, J.‐F. Goussot, C Lagarde, N.B. Bui and H Mouriesse. Their work appears in journals such as Cancer, Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.